[HTML][HTML] Mechanisms of temozolomide resistance in glioblastoma-a comprehensive review

N Singh, A Miner, L Hennis, S Mittal - Cancer drug resistance, 2021 - ncbi.nlm.nih.gov
Glioblastoma (GBM) is the most common primary malignant brain tumor in adults and has an
exceedingly low median overall survival of only 15 months. Current standard-of-care for …

Potential strategies overcoming the temozolomide resistance for glioblastoma

S Jiapaer, T Furuta, S Tanaka, T Kitabayashi… - Neurologia medico …, 2018 - jstage.jst.go.jp
Glioblastoma (GBM) is a highly malignant type of primary brain tumor with a high mortality
rate. Although the current standard therapy consists of surgery followed by radiation and …

Ketogenic diet in cancer prevention and therapy: molecular targets and therapeutic opportunities

WH Talib, AI Mahmod, A Kamal, HM Rashid… - Current issues in …, 2021 - mdpi.com
Although cancer is still one of the most significant global challenges facing public health, the
world still lacks complementary approaches that would significantly enhance the efficacy of …

microRNAs (miRNAs) in glioblastoma multiforme (GBM)—recent literature review

M Makowska, B Smolarz, H Romanowicz - International Journal of …, 2023 - mdpi.com
Glioblastoma multiforme (GBM) is the most common, malignant, poorly promising primary
brain tumor. GBM is characterized by an infiltrating growth nature, abundant vascularization …

The roles of miRNA in glioblastoma tumor cell communication: diplomatic and aggressive negotiations

A Buruiană, ȘI Florian, AI Florian, TL Timiș… - International journal of …, 2020 - mdpi.com
Glioblastoma (GBM) consists of a heterogeneous collection of competing cellular clones
which communicate with each other and with the tumor microenvironment (TME) …

[HTML][HTML] Role of microRNAs in glioblastoma

M Chen, Z Medarova, A Moore - Oncotarget, 2021 - ncbi.nlm.nih.gov
Glioblastoma is the most common and aggressive primary human brain cancer. MicroRNAs
(miRNAs) are a set of small endogenous non-coding RNA molecules which play critical …

[HTML][HTML] MicroRNAs as prognostic markers and therapeutic targets in gliomas

A Sufianov, S Begliarzade, T Ilyasova, Y Liang… - Non-coding RNA …, 2022 - Elsevier
Gliomas are invasive brain tumors characterized by high rates of recurrence and mortality.
Glioblastoma (GBM), a grade IV brain tumor, is known for its heterogenicity and its …

Dissecting tumor antigens and immune subtypes of glioma to develop mRNA vaccine

H Zhong, S Liu, F Cao, Y Zhao, J Zhou, F Tang… - Frontiers in …, 2021 - frontiersin.org
Background Nowadays, researchers are leveraging the mRNA-based vaccine technology
used to develop personalized immunotherapy for cancer. However, its application against …

microRNA-181 serves as a dual-role regulator in the development of human cancers

T Rezaei, M Amini, ZS Hashemi, B Mansoori… - Free Radical Biology …, 2020 - Elsevier
MicroRNAs (miRNAs) as the regulatory short noncoding RNAs are involved in a wide array
of cellular and molecular processes. They negatively regulate gene expression and their …

H19 promotes non‐small‐cell lung cancer (NSCLC) development through STAT3 signaling via sponging miR‐17

Z Huang, W Lei, HB Hu, H Zhang… - Journal of cellular …, 2018 - Wiley Online Library
LncRNAs can exhibit crucial roles in the development of multiple cancers, including non‐
small cell lung cancer (NSCLC). Currently, we investigated the role of lncRNA H19 in …